Wilgenhof, Sofie
The Netherlands Cancer Institute
2 papers on CoChatORCID 0000-0002-3309-4555
Most cited papers
- Verified
Phase I/Ib Clinical Trial of Sabatolimab, an Anti‐TIM‐3 Antibody, Alone and in Combination with Spartalizumab, an Anti‐PD‐1 Antibody, in Advanced Solid Tumors
Curigliano, G., Gelderblom, H., Mach, N., Doi, T., Tai, D., Forde, P. M., Sarantopoulos, J., Bedard, P. L., Lin, C.-C., Hodi, F. S., et al. (2021) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 362
- Verified
Usability and Usefulness of a Symptom Management Coaching System for Patients With Cancer Treated With Immune Checkpoint Inhibitors: Comparative Mixed Methods Study
Glaser, S. L. C., Fraterman, I., van Brummelen, N., Tibollo, V., Del Campo, L. M., Mallo, H., Wilgenhof, S., Wilk, S., Gisko, V., Khadakou, V., et al. (2025) · JMIR Formative Research
Mobile Health and mHealth ApplicationsUsability and User Interface Design
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free